当前位置:首页 - 行情中心 - 普洛药业(000739) - 财务分析

普洛药业

(000739)

  

流通市值:186.09亿  总市值:186.16亿
流通股本:11.58亿   总股本:11.58亿

普洛药业(000739)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润5.63亿元,每股收益0.49元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益675650.61万元,未分配利润523873.72万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产1248361.14万元,负债572710.53万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入5,444,486,087.312,730,189,121.9712,021,863,029.219,290,220,207.76
营业总成本4,838,162,638.12,490,659,565.2810,858,989,886.758,295,069,270.45
其他经营收益
营业利润660,249,384.93298,437,200.121,212,070,903.261,023,122,464.97
利润总额658,587,798.37297,471,282.941,203,290,373.011,019,844,330.67
净利润563,071,412.09248,576,261.581,030,846,722.3869,388,123.84
每股收益
其他综合收益318,525.6391,753.6610,713,506.83,571,372.34
综合收益总额563,389,937.72248,668,015.241,041,560,229.1872,959,496.18
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计8,011,650,969.638,228,646,015.778,186,761,774.668,782,088,664.2
非流动资产:
非流动资产合计4,471,960,429.194,479,894,940.954,542,246,835.54,557,277,677.88
资产总计12,483,611,398.8212,708,540,956.7212,729,008,610.1613,339,366,342.08
流动负债:
流动负债合计5,382,021,923.245,466,974,634.365,742,629,852.136,476,686,297.59
非流动负债:
非流动负债合计345,083,373.18243,015,127.4236,495,578.31274,902,708.89
负债合计5,727,105,296.425,709,989,761.765,979,125,430.446,751,589,006.48
所有者权益(或股东权益):
归属于母公司股东权益合计6,748,563,568.946,990,603,683.936,741,964,785.166,579,848,258.66
股东权益合计6,756,506,102.46,998,551,194.966,749,883,179.726,587,777,335.6
负债和股东权益合计12,483,611,398.8212,708,540,956.7212,729,008,610.1613,339,366,342.08
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计4,128,407,073.222,227,671,600.3910,411,469,786.978,083,217,866.85
经营活动现金流出小计3,721,226,512.92,242,665,069.559,202,716,103.966,917,508,752.01
经营活动产生的现金流量净额407,180,560.32-14,993,469.161,208,753,683.011,165,709,114.84
投资活动产生的现金流量:
投资活动现金流入小计543,989,471.66271,293,102.69898,626,068.92243,447,417.35
投资活动现金流出小计672,733,223.93362,663,790.841,296,637,801.32607,985,493.56
投资活动产生的现金流量净额-128,743,752.27-91,370,688.15-398,011,732.4-364,538,076.21
筹资活动产生的现金流量:
筹资活动现金流入小计1,062,900,000296,900,0001,388,885,064.791,005,505,050
筹资活动现金流出小计1,283,559,126.65328,296,306.271,971,036,445.911,538,035,740.54
筹资活动产生的现金流量净额-220,659,126.65-31,396,306.27-582,151,381.12-532,530,690.54
汇率变动对现金及现金等价物的影响7,432,261.763,246,242.9338,368,228.834,431,426.13
现金及现金等价物净增加额65,209,943.16-134,514,220.65266,958,798.32273,071,774.22
期末现金及现金等价物余额2,794,654,503.222,594,930,339.412,729,444,560.062,735,557,535.96
补充资料:
现金及现金等价物的净增加额65,209,943.16-266,958,798.32-
最新报告期:2025-08-26
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
信达证券唐爱金0.931.111.312025-08-26
中泰证券祝嘉琦0.961.091.252025-08-26
招商证券侯彪,梁广楷,许菲菲0.871.051.312025-08-21
财通证券邹一瑜0.881.051.262025-08-21
开源证券阮帅,余汝意1.021.191.432025-08-21
TOP↑